Filing Details
- Accession Number:
- 0001231977-11-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-12 16:29:36
- Reporting Period:
- 2011-07-11
- Filing Date:
- 2011-07-12
- Accepted Time:
- 2011-07-12 16:29:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1457477 | David Hallal | C/O Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410 | Svp, Global Commercial Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Disposition | 2011-07-11 | 501 | $50.00 | 30,290 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These sales were made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock.
- Reporting person's ownership reflects the 2-for-1 common stock split effected by Alexion in the form of a dividend on May 20, 2011.
Billionaire Hedge Funds
